Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adiponectin receptor 1 pseudogene 2 (ADIPOR1P2) is a non-functional genomic DNA sequence with high similarity to the functional Adiponectin receptor 1 gene (ADIPOR1), but it does not encode a functional protein and is not considered a receptor or therapeutic target. It is annotated as a pseudogene, meaning it has lost its protein-coding potential through evolutionary processes, such as mutations or truncations. Pseudogenes are generally noncoding, can rarely regulate gene expression through RNA-based mechanisms, and may complicate genetic studies due to sequence similarity with their parent genes. There is no evidence for ADIPOR1P2 functioning in human biology or disease, nor is it a target for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adiponectin receptor 1 pseudogene 2 (ADIPOR1P2).